News

05 Nov PfizerPledge™: A Pilot Warranty Program for XALKORI

Posted at 15:16h in News

Over the last few months, Pfizer has quietly developed PfizerPledge™, a pilot warranty program for XALKORI that offers warranty payments to patients and health plans in full, if patients discontinue treatment for a clinical reason before the dispense of the fourth 30-day supply. Though not...

03 Aug Jupiter Life Sciences Consulting Welcomes Catherine Beecher as Partner

Posted at 13:42h in News

LONDON – 3rd August 2021 Jupiter Life Sciences Consulting, a global leader in pricing and market access strategy in the biopharmaceutical industry, are delighted to announce the appointment of Catherine Beecher (Cathy) as Partner. Cathy will strengthen and help build the growing European team and provide...

16 Jun Aduhelm Pricing Considerations

Posted at 11:59h in News

On June 7th 2021, the FDA made a landmark decision in clearing Aduhelm under the accelerated approval pathway for Alzheimer's disease. As the first therapy approved in the category in nearly two decades, Aduhelm provides an option for patients with this highly debilitating disease; however,...

16 Nov UnitedHealthcare Delays Medical Benefit Accumulator, Anthem Plows Forward

Posted at 16:44h in News

November 2020 In October 2020, UnitedHealthcare introduced an Accumulator Adjustment Medical Benefit Program, the first of its kind to be specific to the medical benefit [1]. Accumulator programs aim to leverage the copay assistance programs offered by the manufacturer, to prevent them from counting towards a...

16 May Addressing the opioid crisis: abuse deterrent-formulations and the future of pain management

Posted at 13:13h in News

The opioid epidemic in the United States is a serious national crisis that affects public health as social and economic welfare. From 1999 to 2017, more than 700,000 people died from a drug overdose; of which, 218,000 were related to prescription opioid use/abuse.1 In 2017...

21 Jan Jupiter Life Sciences Consulting Announces Saleem J Shah as Partner

Posted at 14:30h in News

LONDON – Jan. 21, 2019 Jupiter Life Sciences Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, are delighted to announce the appointment of Saleem J Shah (Sal) as Partner. Based in London, Sal will build and lead European...

13 Feb Jupiter Life Science Consulting Launches New Subscription-Based Market Research Solution for Pharma and Biotech Industries

Posted at 17:26h in News

BOSTON – Feb. 13, 2018 – Jupiter Life Science Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, today announced the launch of its payer engagement solution, Quick Qual (Q2). Jupiter’s new payer intelligence service ensures pharma and biotech innovators...

12 Dec Jupiter Life Science Consulting Acquires Alta Bioscience Consulting

Posted at 22:05h in News

BOSTON – Dec. 12, 2017 – Jupiter Life Science Consulting, a global leader in market access and pricing strategy in the biopharmaceutical industry, today announced the acquisition of Alta Bioscience Consulting. Alta is a global provider of advisory services in the development and commercialization of...